Y-mAbs Therapeutics, Inc.

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/13/2025

14,596

Value ($000)

Weight

0.0%

2020 Q2 - 2025 Q2 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/13/2025	66	0.0%	14,596	6/30/2025
2025 Q1	5/12/2025	65	0.0%	14,596	3/31/2025
2024 Q4	2/10/2025	114	0.0%	14,596	12/31/2024
2024 Q3	11/8/2024	192	0.0%	14,596	9/30/2024
2024 Q2	8/8/2024	176	0.0%	14,596	6/30/2024
2024 Q1	5/8/2024	72	0.0%	14,306	3/31/2024
2023 Q4	2/9/2024	100	0.0%	14,596	12/31/2023
2023 Q3	11/8/2023	80	0.0%	14,596	9/30/2023
2023 Q2	8/11/2023	97	0.0%	14,306	6/30/2023
2023 Q1	6/14/2023	72	0.0%	14,306	3/31/2023
2022 Q4	6/14/2023	70	0.0%	14,306	12/31/2022
2022 Q3	11/8/2022	218	0.0%	15,096	9/30/2022
2022 Q2	8/5/2022	228	0.0%	15,096	6/30/2022
2022 Q1	5/6/2022	133	0.0%	11,156	3/31/2022
2021 Q4	2/8/2022	181	0.0%	11,156	12/31/2021
2021 Q3	11/8/2021	314	0.0%	11,019	9/30/2021
2021 Q2	8/10/2021	372	0.0%	11,019	6/30/2021
2021 Q1	5/10/2021	267	0.0%	8,845	3/31/2021
2020 Q4	2/8/2021	431	0.0%	8,715	12/31/2020
2020 Q3	11/9/2020	335	0.0%	8,715	9/30/2020
2020 Q2	8/7/2020	352	0.0%	8,145	6/30/2020